TRISALUS LIFE SCIENCES

Lobbying Spend

—

Filings

Firms Hired

Active Period

2018–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	5	1
2024	—	7	2
2023	—	11	3
2022	—	12	3
2021	—	8	3
2020	—	4	1
2019	—	4	1
2018	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CAPITOL HILL CONSULTING GROUP	—	22
ALSTON & BIRD LLP	—	13
COMMONWEALTH POLICY SOLUTIONS	—	22

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	53
SENATE	53
Centers For Medicare and Medicaid Services (CMS)	32
Health & Human Services, Dept of (HHS)	21

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	56
Health Issues	Health Issues	34
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	22
Veterans	Veterans	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 9559117th Congress

Innovative Technologies Impacted by COVID–19 Act

2022 · fourth_quarter · Firm: ALSTON & BIRD LLP

Cited source text and reported amounts

General health care issues; H.R.9559, Innovative Technologies Impacted by COVID-19 Act.

Client expense: — · Firm income: $90,000

Matched citations: H.R.9559